Purchase Order HHSF223201400017P

Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...

This firm fixed-price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to CDI Laboratories Inc. of Mayagüez, Puerto Rico for $200,167.30. The contract calls for the delivery of CDI Biolabs HuProt v4.0 and VirD protein arrays within 90 days of the award date. The HuProt v4.0 array contains over 21,000 human proteins from more than 16,000 genes and has a reproducibility rate above 95%. The VirD array profiles 515 conformationally intact human...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...

This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...

The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Aushon Biosystems, Inc. for the provision of "CUSTOM CYTOKINE ARRAY SAMPLES" with a total ceiling value of $22,253.00. The contract has no set-aside designation and was awarded on July 28, 2011 with an ultimate completion date of September 30, 2011. Aushon Biosystems, Inc. is a for-profit...

The U.S. Department of Agriculture (USDA) Agricultural Research Service awarded a $16.1K firm fixed-price purchase order to CD Biosciences Inc. (doing business as Creative Biomart) for development of a single domain antibody library. The contract, issued on July 6, 2016, with an ultimate completion date of August 5, 2016, encompasses animal immunization, RNA purification, polymerase chain reaction (PCR) amplification of antibody repertoires, ligation, and transformation services. The work is...

This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Agilent Technologies Inc. for the provision of custom microarray services. The contract was awarded under the GSA Scientific Equipment and Services Schedule (FSS-66) on a Firm Fixed Price basis, with a ceiling value of $14,389.20 and a completion date of September 4, 2015. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, and has a...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, to provide antibody efficiency testing services. The $119,213.05 contract has a completion date of September 30, 2022 and does not utilize a set-aside designation. Genscript previously held a $1.5 million blanket purchase agreement with the U.S. Department of...

This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company. The $118,272.00 contract is for the provision of customized antibody expressions and plasmid preparations to support biomedical research and public health initiatives. The award has a completion date of November 1, 2020 and does not include a set-aside designation. Genscript...